サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1771971

ペプチド CRDMOの世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)

Global Peptide CRDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

出版日
発行
QYResearch
ページ情報
英文 103 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
ペプチド CRDMOの世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)
出版日: 2025年07月17日
発行: QYResearch
ページ情報: 英文 103 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、ペプチド CRDMO (Peptide CRDMO) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場：タイプ別
    • 世界のタイプ別市場成長: 2020 VS 2024 VS 2031
    • Solid-Phase Peptide Synthesis
    • Liquid-Phase Peptide Synthesis
  • 市場：用途別
    • 世界の用途別市場シェア: 2020 VS 2024 VS 2031
    • Pharmaceuticals
    • Scientific Research
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界のペプチド CRDMOの市場展望 (2020-2031)
  • 世界の市場規模：地域別: 2020 VS 2024 VS 2031
  • 世界のペプチド CRDMOの収益市場シェア 地域別 (2020-2025)
  • 世界のペプチド CRDMOの収益予測：地域別 (2026-2031)
  • 主要地域と新興市場分析
    • 北米のペプチド CRDMO 市場規模および予測 (2020-2031)
    • 欧州のペプチド CRDMO 市場規模および予測 (2020-2031)
    • 中国のペプチド CRDMO 市場規模および予測 (2020-2031)
    • 日本のペプチド CRDMO 市場規模および予測 (2020-2031)
    • 東南アジア ペプチド CRDMO 市場規模および予測 (2020-2031)
    • インド ペプチド CRDMO 市場規模および予測 (2020-2031)
    • 南アメリカ ペプチド CRDMO 市場規模および予測 (2020-2031)
    • 中東 ペプチド CRDMO 市場規模および予測 (2020-2031)

第3章 内訳データ：タイプ別

  • 世界のペプチド CRDMOの市場規模実績：タイプ別 (2020-2025)
  • 世界のペプチド CRDMOの市場規模予測：タイプ別 (2026-2031)
  • 各種タイプ ペプチド CRDMO 代表的な企業

第4章 内訳データ：用途別

  • 世界のペプチド CRDMOの市場規模実績：用途別 (2020-2025)
  • 世界のペプチド CRDMOの市場規模予測：用途別 (2026-2031)
  • 新たな成長源 ペプチド CRDMO アプリケーション

第5章 競合他社の状況

  • 世界トップ企業 収益
    • 世界のペプチド CRDMOの上位企業：収益別 (2020-2025)
    • 世界のペプチド CRDMOの収益シェア：企業別 (2020-2025)
  • 世界の企業タイプ別市場シェア (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング： ペプチド CRDMO 収益
  • 世界のペプチド CRDMO 市場集中度分析
    • 世界のペプチド CRDMO 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： ペプチド CRDMO 収益 2024年
  • 世界の主要企業 ペプチド CRDMO 本社 および提供地域
  • 世界の主要企業 ペプチド CRDMO, 製品およびアプリケーション
  • 世界の主要企業 ペプチド CRDMO, 業界参入時期
  • M&A, 拡張計画

第6章 地域分析

  • 北米の市場: Pレイヤー, セグメントs and 下流
    • 北米のペプチド CRDMO 企業別収益 (2020-2025)
    • 北米の市場規模：タイプ別
    • 北米の市場規模：用途別
    • 北米の市場 トレンドと機会
  • 欧州の市場: Pレイヤー, セグメントs and 下流
    • 欧州のペプチド CRDMO 企業別収益 (2020-2025)
    • 欧州の市場規模：タイプ別
    • 欧州の市場規模：用途別
    • 欧州の市場 トレンドと機会
  • 中国の市場: Pレイヤー, セグメントs and 下流
    • 中国のペプチド CRDMO 企業別収益 (2020-2025)
    • 中国の市場規模：タイプ別
    • 中国の市場規模：用途別
    • 中国の市場 トレンドと機会
  • 日本の市場: Pレイヤー, セグメントs and 下流
    • 日本のペプチド CRDMO 企業別収益 (2020-2025)
    • 日本の市場規模：タイプ別
    • 日本の市場規模：用途別
    • 日本の市場 トレンドと機会
  • 東南アジア 市場: Pレイヤー, セグメントs and 下流
    • 東南アジア ペプチド CRDMO 企業別収益 (2020-2025)
    • 東南アジア 市場規模：タイプ別
    • 東南アジア 市場規模：用途別
    • 東南アジア 市場 トレンドと機会
  • インド 市場: Pレイヤー, セグメントs and 下流
    • インド ペプチド CRDMO 企業別収益 (2020-2025)
    • インド 市場規模：タイプ別
    • インド 市場規模：用途別
    • インド 市場 トレンドと機会

第7章 主要企業のプロファイル

  • Bachem
  • PolyPeptide
  • Ambio
  • USV Peptide
  • BCNpeptides
  • Lonza
  • CordenPharma
  • PeptiDream
  • AmbioPharm
  • CPC Scientific
  • Sinopep
  • SynZeal
  • Cambrex Corporation
  • Tide Pharmaceutical
  • Hybio Pharmaceutical
  • Rochi Pharma

第8章 ペプチド CRDMO 市場動向

  • ペプチド CRDMO 業界動向
  • ペプチド CRDMO 市場の促進要因
  • ペプチド CRDMO 市場の課題
  • ペプチド CRDMO 市場の抑制要因

第9章 市場調査結果と結論

第10章 付録

図表

List of Tables

Table 1. Global Peptide CRDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Peptide CRDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Peptide CRDMO Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Peptide CRDMO Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Peptide CRDMO Revenue Share by Region (2020-2025)

Table 6. Global Peptide CRDMO Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Peptide CRDMO Revenue Share Forecast by Region (2026-2031)

Table 8. Global Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Peptide CRDMO Revenue Market Share by Type (2020-2025)

Table 10. Global Peptide CRDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Peptide CRDMO Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Peptide CRDMO Revenue Market Share by Application (2020-2025)

Table 15. Global Peptide CRDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Peptide CRDMO Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Peptide CRDMO Application

Table 18. Global Peptide CRDMO Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Peptide CRDMO Market Share by Players (2020-2025)

Table 20. Global Top Peptide CRDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CRDMO as of 2024)

Table 21. Ranking of Global Top Peptide CRDMO Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Peptide CRDMO Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Peptide CRDMO, Headquarters and Area Served

Table 24. Global Key Players of Peptide CRDMO, Product and Application

Table 25. Global Key Players of Peptide CRDMO, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Peptide CRDMO Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Peptide CRDMO Revenue Market Share by Company (2020-2025)

Table 29. North America Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Peptide CRDMO Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Peptide CRDMO Revenue Market Share by Company (2020-2025)

Table 33. Europe Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Peptide CRDMO Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Peptide CRDMO Revenue Market Share by Company (2020-2025)

Table 37. China Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Peptide CRDMO Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Peptide CRDMO Revenue Market Share by Company (2020-2025)

Table 41. Japan Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 43. Southeast Asia Peptide CRDMO Revenue by Company (2020-2025) & (US$ Million)

Table 44. Southeast Asia Peptide CRDMO Revenue Market Share by Company (2020-2025)

Table 45. Southeast Asia Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 46. Southeast Asia Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 47. India Peptide CRDMO Revenue by Company (2020-2025) & (US$ Million)

Table 48. India Peptide CRDMO Revenue Market Share by Company (2020-2025)

Table 49. India Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 50. India Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 51. Bachem Company Details

Table 52. Bachem Business Overview

Table 53. Bachem Peptide CRDMO Product

Table 54. Bachem Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 55. Bachem Recent Development

Table 56. PolyPeptide Company Details

Table 57. PolyPeptide Business Overview

Table 58. PolyPeptide Peptide CRDMO Product

Table 59. PolyPeptide Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 60. PolyPeptide Recent Development

Table 61. Ambio Company Details

Table 62. Ambio Business Overview

Table 63. Ambio Peptide CRDMO Product

Table 64. Ambio Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 65. Ambio Recent Development

Table 66. USV Peptide Company Details

Table 67. USV Peptide Business Overview

Table 68. USV Peptide Peptide CRDMO Product

Table 69. USV Peptide Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 70. USV Peptide Recent Development

Table 71. BCNpeptides Company Details

Table 72. BCNpeptides Business Overview

Table 73. BCNpeptides Peptide CRDMO Product

Table 74. BCNpeptides Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 75. BCNpeptides Recent Development

Table 76. Lonza Company Details

Table 77. Lonza Business Overview

Table 78. Lonza Peptide CRDMO Product

Table 79. Lonza Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 80. Lonza Recent Development

Table 81. CordenPharma Company Details

Table 82. CordenPharma Business Overview

Table 83. CordenPharma Peptide CRDMO Product

Table 84. CordenPharma Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 85. CordenPharma Recent Development

Table 86. PeptiDream Company Details

Table 87. PeptiDream Business Overview

Table 88. PeptiDream Peptide CRDMO Product

Table 89. PeptiDream Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 90. PeptiDream Recent Development

Table 91. AmbioPharm Company Details

Table 92. AmbioPharm Business Overview

Table 93. AmbioPharm Peptide CRDMO Product

Table 94. AmbioPharm Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 95. AmbioPharm Recent Development

Table 96. CPC Scientific Company Details

Table 97. CPC Scientific Business Overview

Table 98. CPC Scientific Peptide CRDMO Product

Table 99. CPC Scientific Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 100. CPC Scientific Recent Development

Table 101. Sinopep Company Details

Table 102. Sinopep Business Overview

Table 103. Sinopep Peptide CRDMO Product

Table 104. Sinopep Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 105. Sinopep Recent Development

Table 106. SynZeal Company Details

Table 107. SynZeal Business Overview

Table 108. SynZeal Peptide CRDMO Product

Table 109. SynZeal Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 110. SynZeal Recent Development

Table 111. Cambrex Corporation Company Details

Table 112. Cambrex Corporation Business Overview

Table 113. Cambrex Corporation Peptide CRDMO Product

Table 114. Cambrex Corporation Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 115. Cambrex Corporation Recent Development

Table 116. Tide Pharmaceutical Company Details

Table 117. Tide Pharmaceutical Business Overview

Table 118. Tide Pharmaceutical Peptide CRDMO Product

Table 119. Tide Pharmaceutical Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 120. Tide Pharmaceutical Recent Development

Table 121. Hybio Pharmaceutical Company Details

Table 122. Hybio Pharmaceutical Business Overview

Table 123. Hybio Pharmaceutical Peptide CRDMO Product

Table 124. Hybio Pharmaceutical Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 125. Hybio Pharmaceutical Recent Development

Table 126. Rochi Pharma Company Details

Table 127. Rochi Pharma Business Overview

Table 128. Rochi Pharma Peptide CRDMO Product

Table 129. Rochi Pharma Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 130. Rochi Pharma Recent Development

Table 131. Peptide CRDMO Market Trends

Table 132. Peptide CRDMO Market Drivers

Table 133. Peptide CRDMO Market Challenges

Table 134. Peptide CRDMO Market Restraints

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

List of Figures

Figure 1. Peptide CRDMO Product Picture

Figure 2. Global Peptide CRDMO Market Share by Type: 2024 VS 2031

Figure 3. Solid-Phase Peptide Synthesis Features

Figure 4. Liquid-Phase Peptide Synthesis Features

Figure 5. Global Peptide CRDMO Market Share by Application: 2024 VS 2031

Figure 6. Pharmaceuticals

Figure 7. Scientific Research

Figure 8. Others

Figure 9. Peptide CRDMO Report Years Considered

Figure 10. Global Peptide CRDMO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 11. Global Peptide CRDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Peptide CRDMO Revenue Market Share by Region: 2020 VS 2024

Figure 13. North America Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 14. Europe Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 15. China Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. Japan Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Southeast Asia Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. India Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. South America Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Middle East Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Global Peptide CRDMO Market Share by Players in 2024

Figure 22. Global Top Peptide CRDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CRDMO as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Peptide CRDMO Revenue in 2024

Figure 24. North America Peptide CRDMO Market Share by Type (2020-2025)

Figure 25. North America Peptide CRDMO Market Share by Application (2020-2025)

Figure 26. Europe Peptide CRDMO Market Share by Type (2020-2025)

Figure 27. Europe Peptide CRDMO Market Share by Application (2020-2025)

Figure 28. China Peptide CRDMO Market Share by Type (2020-2025)

Figure 29. China Peptide CRDMO Market Share by Application (2020-2025)

Figure 30. Japan Peptide CRDMO Market Share by Type (2020-2025)

Figure 31. Japan Peptide CRDMO Market Share by Application (2020-2025)

Figure 32. Southeast Asia Peptide CRDMO Market Share by Type (2020-2025)

Figure 33. Southeast Asia Peptide CRDMO Market Share by Application (2020-2025)

Figure 34. India Peptide CRDMO Market Share by Type (2020-2025)

Figure 35. India Peptide CRDMO Market Share by Application (2020-2025)

Figure 36. Bachem Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 37. PolyPeptide Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 38. Ambio Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 39. USV Peptide Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 40. BCNpeptides Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 41. Lonza Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 42. CordenPharma Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 43. PeptiDream Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 44. AmbioPharm Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 45. CPC Scientific Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 46. Sinopep Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 47. SynZeal Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 48. Cambrex Corporation Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 49. Tide Pharmaceutical Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 50. Hybio Pharmaceutical Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 51. Rochi Pharma Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

目次

This research report focuses on the Peptide CRDMO Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market by Type
    • 1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
    • 1.2.2 Solid-Phase Peptide Synthesis
    • 1.2.3 Liquid-Phase Peptide Synthesis
  • 1.3 Market by Application
    • 1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
    • 1.3.2 Pharmaceuticals
    • 1.3.3 Scientific Research
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Peptide CRDMO Market Perspective (2020-2031)
  • 2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
  • 2.3 Global Peptide CRDMO Revenue Market Share by Region (2020-2025)
  • 2.4 Global Peptide CRDMO Revenue Forecast by Region (2026-2031)
  • 2.5 Major Region and Emerging Market Analysis
    • 2.5.1 North America Peptide CRDMO Market Size and Prospective (2020-2031)
    • 2.5.2 Europe Peptide CRDMO Market Size and Prospective (2020-2031)
    • 2.5.3 China Peptide CRDMO Market Size and Prospective (2020-2031)
    • 2.5.4 Japan Peptide CRDMO Market Size and Prospective (2020-2031)
    • 2.5.5 Southeast Asia Peptide CRDMO Market Size and Prospective (2020-2031)
    • 2.5.6 India Peptide CRDMO Market Size and Prospective (2020-2031)
    • 2.5.7 South America Peptide CRDMO Market Size and Prospective (2020-2031)
    • 2.5.8 Middle East Peptide CRDMO Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

  • 3.1 Global Peptide CRDMO Historic Market Size by Type (2020-2025)
  • 3.2 Global Peptide CRDMO Forecasted Market Size by Type (2026-2031)
  • 3.3 Different Types Peptide CRDMO Representative Players

4 Breakdown Data by Application

  • 4.1 Global Peptide CRDMO Historic Market Size by Application (2020-2025)
  • 4.2 Global Peptide CRDMO Forecasted Market Size by Application (2026-2031)
  • 4.3 New Sources of Growth in Peptide CRDMO Application

5 Competition Landscape by Players

  • 5.1 Global Top Players by Revenue
    • 5.1.1 Global Top Peptide CRDMO Players by Revenue (2020-2025)
    • 5.1.2 Global Peptide CRDMO Revenue Market Share by Players (2020-2025)
  • 5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 5.3 Players Covered: Ranking by Peptide CRDMO Revenue
  • 5.4 Global Peptide CRDMO Market Concentration Analysis
    • 5.4.1 Global Peptide CRDMO Market Concentration Ratio (CR5 and HHI)
    • 5.4.2 Global Top 10 and Top 5 Companies by Peptide CRDMO Revenue in 2024
  • 5.5 Global Key Players of Peptide CRDMO Head office and Area Served
  • 5.6 Global Key Players of Peptide CRDMO, Product and Application
  • 5.7 Global Key Players of Peptide CRDMO, Date of Enter into This Industry
  • 5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

  • 6.1 North America Market: Players, Segments and Downstream
    • 6.1.1 North America Peptide CRDMO Revenue by Company (2020-2025)
    • 6.1.2 North America Market Size by Type
      • 6.1.2.1 North America Peptide CRDMO Market Size by Type (2020-2025)
      • 6.1.2.2 North America Peptide CRDMO Market Share by Type (2020-2025)
    • 6.1.3 North America Market Size by Application
      • 6.1.3.1 North America Peptide CRDMO Market Size by Application (2020-2025)
      • 6.1.3.2 North America Peptide CRDMO Market Share by Application (2020-2025)
    • 6.1.4 North America Market Trend and Opportunities
  • 6.2 Europe Market: Players, Segments and Downstream
    • 6.2.1 Europe Peptide CRDMO Revenue by Company (2020-2025)
    • 6.2.2 Europe Market Size by Type
      • 6.2.2.1 Europe Peptide CRDMO Market Size by Type (2020-2025)
      • 6.2.2.2 Europe Peptide CRDMO Market Share by Type (2020-2025)
    • 6.2.3 Europe Market Size by Application
      • 6.2.3.1 Europe Peptide CRDMO Market Size by Application (2020-2025)
      • 6.2.3.2 Europe Peptide CRDMO Market Share by Application (2020-2025)
    • 6.2.4 Europe Market Trend and Opportunities
  • 6.3 China Market: Players, Segments and Downstream
    • 6.3.1 China Peptide CRDMO Revenue by Company (2020-2025)
    • 6.3.2 China Market Size by Type
      • 6.3.2.1 China Peptide CRDMO Market Size by Type (2020-2025)
      • 6.3.2.2 China Peptide CRDMO Market Share by Type (2020-2025)
    • 6.3.3 China Market Size by Application
      • 6.3.3.1 China Peptide CRDMO Market Size by Application (2020-2025)
      • 6.3.3.2 China Peptide CRDMO Market Share by Application (2020-2025)
    • 6.3.4 China Market Trend and Opportunities
  • 6.4 Japan Market: Players, Segments and Downstream
    • 6.4.1 Japan Peptide CRDMO Revenue by Company (2020-2025)
    • 6.4.2 Japan Market Size by Type
      • 6.4.2.1 Japan Peptide CRDMO Market Size by Type (2020-2025)
      • 6.4.2.2 Japan Peptide CRDMO Market Share by Type (2020-2025)
    • 6.4.3 Japan Market Size by Application
      • 6.4.3.1 Japan Peptide CRDMO Market Size by Application (2020-2025)
      • 6.4.3.2 Japan Peptide CRDMO Market Share by Application (2020-2025)
    • 6.4.4 Japan Market Trend and Opportunities
  • 6.5 Southeast Asia Market: Players, Segments and Downstream
    • 6.5.1 Southeast Asia Peptide CRDMO Revenue by Company (2020-2025)
    • 6.5.2 Southeast Asia Market Size by Type
      • 6.5.2.1 Southeast Asia Peptide CRDMO Market Size by Type (2020-2025)
      • 6.5.2.2 Southeast Asia Peptide CRDMO Market Share by Type (2020-2025)
    • 6.5.3 Southeast Asia Market Size by Application
      • 6.5.3.1 Southeast Asia Peptide CRDMO Market Size by Application (2020-2025)
      • 6.5.3.2 Southeast Asia Peptide CRDMO Market Share by Application (2020-2025)
    • 6.5.4 Southeast Asia Market Trend and Opportunities
  • 6.6 India Market: Players, Segments and Downstream
    • 6.6.1 India Peptide CRDMO Revenue by Company (2020-2025)
    • 6.6.2 India Market Size by Type
      • 6.6.2.1 India Peptide CRDMO Market Size by Type (2020-2025)
      • 6.6.2.2 India Peptide CRDMO Market Share by Type (2020-2025)
    • 6.6.3 India Market Size by Application
      • 6.6.3.1 India Peptide CRDMO Market Size by Application (2020-2025)
      • 6.6.3.2 India Peptide CRDMO Market Share by Application (2020-2025)
    • 6.6.4 India Market Trend and Opportunities

7 Key Players Profiles

  • 7.1 Bachem
    • 7.1.1 Bachem Company Details
    • 7.1.2 Bachem Business Overview
    • 7.1.3 Bachem Peptide CRDMO Introduction
    • 7.1.4 Bachem Revenue in Peptide CRDMO Business (2020-2025)
    • 7.1.5 Bachem Recent Development
  • 7.2 PolyPeptide
    • 7.2.1 PolyPeptide Company Details
    • 7.2.2 PolyPeptide Business Overview
    • 7.2.3 PolyPeptide Peptide CRDMO Introduction
    • 7.2.4 PolyPeptide Revenue in Peptide CRDMO Business (2020-2025)
    • 7.2.5 PolyPeptide Recent Development
  • 7.3 Ambio
    • 7.3.1 Ambio Company Details
    • 7.3.2 Ambio Business Overview
    • 7.3.3 Ambio Peptide CRDMO Introduction
    • 7.3.4 Ambio Revenue in Peptide CRDMO Business (2020-2025)
    • 7.3.5 Ambio Recent Development
  • 7.4 USV Peptide
    • 7.4.1 USV Peptide Company Details
    • 7.4.2 USV Peptide Business Overview
    • 7.4.3 USV Peptide Peptide CRDMO Introduction
    • 7.4.4 USV Peptide Revenue in Peptide CRDMO Business (2020-2025)
    • 7.4.5 USV Peptide Recent Development
  • 7.5 BCNpeptides
    • 7.5.1 BCNpeptides Company Details
    • 7.5.2 BCNpeptides Business Overview
    • 7.5.3 BCNpeptides Peptide CRDMO Introduction
    • 7.5.4 BCNpeptides Revenue in Peptide CRDMO Business (2020-2025)
    • 7.5.5 BCNpeptides Recent Development
  • 7.6 Lonza
    • 7.6.1 Lonza Company Details
    • 7.6.2 Lonza Business Overview
    • 7.6.3 Lonza Peptide CRDMO Introduction
    • 7.6.4 Lonza Revenue in Peptide CRDMO Business (2020-2025)
    • 7.6.5 Lonza Recent Development
  • 7.7 CordenPharma
    • 7.7.1 CordenPharma Company Details
    • 7.7.2 CordenPharma Business Overview
    • 7.7.3 CordenPharma Peptide CRDMO Introduction
    • 7.7.4 CordenPharma Revenue in Peptide CRDMO Business (2020-2025)
    • 7.7.5 CordenPharma Recent Development
  • 7.8 PeptiDream
    • 7.8.1 PeptiDream Company Details
    • 7.8.2 PeptiDream Business Overview
    • 7.8.3 PeptiDream Peptide CRDMO Introduction
    • 7.8.4 PeptiDream Revenue in Peptide CRDMO Business (2020-2025)
    • 7.8.5 PeptiDream Recent Development
  • 7.9 AmbioPharm
    • 7.9.1 AmbioPharm Company Details
    • 7.9.2 AmbioPharm Business Overview
    • 7.9.3 AmbioPharm Peptide CRDMO Introduction
    • 7.9.4 AmbioPharm Revenue in Peptide CRDMO Business (2020-2025)
    • 7.9.5 AmbioPharm Recent Development
  • 7.10 CPC Scientific
    • 7.10.1 CPC Scientific Company Details
    • 7.10.2 CPC Scientific Business Overview
    • 7.10.3 CPC Scientific Peptide CRDMO Introduction
    • 7.10.4 CPC Scientific Revenue in Peptide CRDMO Business (2020-2025)
    • 7.10.5 CPC Scientific Recent Development
  • 7.11 Sinopep
    • 7.11.1 Sinopep Company Details
    • 7.11.2 Sinopep Business Overview
    • 7.11.3 Sinopep Peptide CRDMO Introduction
    • 7.11.4 Sinopep Revenue in Peptide CRDMO Business (2020-2025)
    • 7.11.5 Sinopep Recent Development
  • 7.12 SynZeal
    • 7.12.1 SynZeal Company Details
    • 7.12.2 SynZeal Business Overview
    • 7.12.3 SynZeal Peptide CRDMO Introduction
    • 7.12.4 SynZeal Revenue in Peptide CRDMO Business (2020-2025)
    • 7.12.5 SynZeal Recent Development
  • 7.13 Cambrex Corporation
    • 7.13.1 Cambrex Corporation Company Details
    • 7.13.2 Cambrex Corporation Business Overview
    • 7.13.3 Cambrex Corporation Peptide CRDMO Introduction
    • 7.13.4 Cambrex Corporation Revenue in Peptide CRDMO Business (2020-2025)
    • 7.13.5 Cambrex Corporation Recent Development
  • 7.14 Tide Pharmaceutical
    • 7.14.1 Tide Pharmaceutical Company Details
    • 7.14.2 Tide Pharmaceutical Business Overview
    • 7.14.3 Tide Pharmaceutical Peptide CRDMO Introduction
    • 7.14.4 Tide Pharmaceutical Revenue in Peptide CRDMO Business (2020-2025)
    • 7.14.5 Tide Pharmaceutical Recent Development
  • 7.15 Hybio Pharmaceutical
    • 7.15.1 Hybio Pharmaceutical Company Details
    • 7.15.2 Hybio Pharmaceutical Business Overview
    • 7.15.3 Hybio Pharmaceutical Peptide CRDMO Introduction
    • 7.15.4 Hybio Pharmaceutical Revenue in Peptide CRDMO Business (2020-2025)
    • 7.15.5 Hybio Pharmaceutical Recent Development
  • 7.16 Rochi Pharma
    • 7.16.1 Rochi Pharma Company Details
    • 7.16.2 Rochi Pharma Business Overview
    • 7.16.3 Rochi Pharma Peptide CRDMO Introduction
    • 7.16.4 Rochi Pharma Revenue in Peptide CRDMO Business (2020-2025)
    • 7.16.5 Rochi Pharma Recent Development

8 Peptide CRDMO Market Dynamics

  • 8.1 Peptide CRDMO Industry Trends
  • 8.2 Peptide CRDMO Market Drivers
  • 8.3 Peptide CRDMO Market Challenges
  • 8.4 Peptide CRDMO Market Restraints

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer